Stocks News Update: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) traded at a yearly high level of $2.55 during the last trading session. The last session’s volume of 7.84 million shares was higher than its average volume of 7.50 million shares. The company has its outstanding shares of 110.36 million. The stock, after opening at $2.28, closed at $2.43 by scoring 7.05%.
This stock is ahead of its 52-week low with +386.97%. Its last month’s stock price volatility remained 10.72% which for the week stands at 13.13%. The share price has moved forward from its 20 days moving average 92.99% and positively from its 50 days moving average 168.97%. The stock inclined 246.65% last month and is up 350.00 this year.
OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) stock reached a 1-year peak price of $1.03. The stock has gained 38.03%, reaching at $0.511 after hovering between $0.35 and $0.57.
This stock is ahead of its 52-week low with +55.70%. Its last month’s stock price volatility remained 19.12% which for the week stands at 9.95%. The stock showed weekly upbeat performance of 45.29%, which was maintained for the month at 44.35%. Likewise, the positive performance for the quarter was recorded as 24.56% and for the year was -49.93%, while the YTD performance remained at 2.16%.
The relative strength index (RSI) is a technical indicator used in the analysis of financial markets. It is intended to chart the current and historical strength or weakness of a stock or market based on the closing prices of a recent trading period. The indicator should not be confused with relative strength.
The RSI is classified as a momentum oscillator, measuring the velocity and magnitude of directional price movements. Momentum is the rate of the rise or fall in price. The RSI computes momentum as the ratio of higher closes to lower closes: stocks which have had more or stronger positive changes have a higher RSI than stocks which have had more or stronger negative changes.
The RSI is most typically used on a 14-day timeframe, measured on a scale from 0 to 100, with high and low levels marked at 70 and 30, respectively. Shorter or longer timeframes are used for alternately shorter or longer outlooks. More extreme high and low levels—80 and 20, or 90 and 10—occur less frequently but indicate stronger momentum. After a recent check, OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)’s 14-day RSI is presently at 84.97.